OnKure Therapeutics, Inc. (OKUR) stock news · rev $3.4M
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
This OKUR news page leads with what OnKure Therapeutics, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for OKUR yet. We will not pad this page with generic market recap.
Latest reported OKUR revenue for 2025-12-31 was $3.4M. Net income was -$59.5M. OKUR currently screens at market cap $76.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the OKUR stock page; for the tape open the quote page.
OKUR stock news FAQ
What are OKUR's latest revenue and net income?
Latest cached OnKure Therapeutics, Inc. (OKUR) revenue for Dec 31, 2025 was $3.4M. Net income was -$59.5M. Statements: https://lician.com/financials/okur
What is OKUR's market cap?
OnKure Therapeutics, Inc. (OKUR) market cap is $76.6M on the latest cached fundamentals snapshot.
What kind of company is OKUR?
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Where is OKUR stock news listed?
Cached stock news for OnKure Therapeutics, Inc. (OKUR) is listed at https://lician.com/news/okur. Filings: https://lician.com/sec/okur
Not investment advice.